PEPentwater Capital Management LP

Institutional investor · Portfolio as of Q1 2021

SEC EDGAR SourceSEC Filings

Top Holdings339 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
MXIMMXIMDelisted

MAXIM INTEGRATED PRODS INC

10.9M$1B9.5%
3 qtrssince 2020-Q3
Increased
74
WORKWORKDelisted

SLACK TECHNOLOGIES INC

19.4M$789.8M7.5%
2 qtrssince 2020-Q4
Increased
66
XLNXXLNXDelisted

XILINX INC

5.8M$723.7M6.9%
2 qtrssince 2020-Q4
Increased
83
ALXNALXNDelisted

ALEXION PHARMACEUTICALS INC

4.3M$655.9M6.3%
2 qtrssince 2020-Q4
Increased
83
1.4M$545.2M5.2%
Decreased
5M$486.3M4.6%
2 qtrssince 2020-Q4
Increased
83
GWPHGWPHDelisted
ADR

GW PHARMACEUTICALS PLC

2.1M$455.9M4.4%
1 qtr
New
87

INPHI CORP

2M$365M3.5%
2 qtrssince 2020-Q4
Increased
84
CLGXCLGXDelisted

CORELOGIC INC

3.9M$310.7M3.0%
3 qtrssince 2020-Q3
Increased
86

COHERENT INC

1.2M$303.5M2.9%$66.580.00%
1 qtr
New
80
TRQTRQDelisted

TURQUOISE HILL RES LTD

18.7M$300.1M2.9%
VARVARDelisted

VARIAN MED SYS INC

1.5M$267.6M2.6%
3 qtrssince 2020-Q3
Increased
58
RPRPDelisted

REALPAGE INC

2.9M$250.9M2.4%
2 qtrssince 2020-Q4
Increased
85
CHNGCHNGDelisted

CHANGE HEALTHCARE INC

9.5M$210M2.0%
8 qtrssince 2019-Q2
Increased
85
GRUBGRUBDelisted

GRUBHUB INC

3.4M$206.7M2.0%
4 qtrssince 2020-Q2
Decreased
0
4M$195.4M1.9%
Increased

P G & E CORP

14.5M$170.2M1.6%$10.96+3.69%
9 qtrssince 2019-Q1
Decreased
0
PRAHPRAHDelisted

PRA HEALTH SCIENCES INC

929,668$142.5M1.4%
1 qtr
New
69
CBCBPODelisted

CHINA BIOLOGIC PRODS HLDGS I

1.2M$140.2M1.3%
7 qtrssince 2019-Q3
Increased
48

KANSAS CITY SOUTHERN

520,000$137.2M1.3%
1 qtr
New
69
$10.5B
AUM
339
Positions
Q1 2021
Filing
Rating · 2.0
Quarterly Portfolio Change
-4%Q4'19$6.1B-1%Q1'20$6.1B-7%Q2'20$5.6B+38%Q3'20$7.7B+7%Q4'20$8.3B+27%Q1'21$10.5B
Activity profile
$ moved · Q1'21
New37%Increased27%Decreased14%Exited22%
Composition
Equity vs derivatives
Equity82%Puts11%Calls6%
Holding period
Avg 2.1 quarters
<1Q50%1-4Q27%1-2Y12%2Y+11%

Pentwater Capital Management LP manages $10.5B across 339 positions as of Q1 2021. Top holdings: MXIM (9.5%), WORK (7.5%), XLNX (6.9%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q1 2021 Summary

Active quarter - 148 new positions, 63 exits, 39 increased. Top move: GWPH (NEW, conviction 87). Portfolio: $10.5B across 339 positions.

Top holdings by portfolio weight

Total AUM$9B
MXIM9.54%
WORK7.54%
XLNX6.90%
ALXN6.26%
IHS MARKIT L4.64%
GWPH4.35%
IPHI3.48%
CLGX2.96%
COHR2.90%
TRQ2.86%
Other2.55%

Portfolio allocation by GICS sector

Sectors11
Unknown86.10%
Technology4.40%
Consumer Cyclical3.17%
Utilities1.98%
Communication Services1.11%
Financial Services0.99%
Real Estate0.93%
Healthcare0.78%
Basic Materials0.24%
Industrials0.13%
Other0.16%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record63
Conviction43
Concentration85
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GEOGEOGEO GROUP INC
Q2 2025 Q2 2026+9.4M shares+$277.5M
4Q
TXNMTXNMPNM RESOURCES INC
Q3 2025 Q2 2026+5.4M shares+$304.9M
3Q
SATSSATSECHOSTAR CORP-A
Q4 2025 Q2 2026+3.2M shares+$342.9M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used